brazikumab,mirikizumab,risankizumab,guselkumab
abbvie,astrazeneca,eli lilly,janssen
['ibd']
another brilliant talk on what s new in #ibd . il23, jak inhibitors, s1p and the future which includes combination biologics 
Associate Professor, Gastroenterologist - IBD, microbiome, Co-founder https://t.co/Xhgfwnb0dG (digital tool -  management of IBD and bowel preparation)